General Atlantic, L.P.

In its 13F for Q2 2025 (holdings as of June 30, 2025, filed August 14, 2025), General Atlantic, L.P. reported 15 stock positions worth $3.6 billion. Its top holding was Dlocal (DLO) at 20.0% of the portfolio, followed by Chime Financial Class A (CHYM, 18.3%) and Alignment Healthcare (ALHC, 17.0%). Compared with Q1 2025, it opened 3 new positions, sold out of 3, added to 1 and reduced 2. The biggest buy was a new position in Chime Financial Class A (CHYM) and the biggest sale Alignment Healthcare (ALHC, shares −28%).

Most Recent 13F
Q2 2026
Location
New York, NY
CIK
0001017645
Portfolio Value
$3.6B (Q2 2025)
SEC Filing
0000950142-25-002176 ↗ filed Aug 14, 2025

Holdings Value

0$1.0B$2.0B$3.0B$4.0B$5.0B Q1 2024: $4.3B Q1 2024 Q2 2024: $3.2B Q2 2024 Q3 2024: $3.5B Q3 2024 Q4 2024: $2.8B Q4 2024 Q1 2025: $3.0B Q1 2025 Q2 2025: $3.6B $3.6B Q2 2025 Q3 2025: $3.3B Q3 2025 Q4 2025: $2.9B Q4 2025 Q1 2026: $2.1B Q1 2026 Q2 2026: $2.9B Q2 2026

Holdings 15 stocks · $3.6B

DLO Dlocal Ltd. 19.97% 63,906,695 $724.7M No change
CHYM Chime Financial Inc. Class A 18.26% 19,208,760 $662.9M New
ALHC Alignment Healthcare Inc. 16.97% 43,993,323 $615.9M Reduce -27.9%
XP XP Inc. Class A 14.20% 25,517,733 $515.5M Reduce -13.8%
AKRO Akero Therapeutics Inc. 8.43% 5,733,989 $306.0M Add +9.6%
ALKT Alkami Technology Inc. 8.01% 9,645,318 $290.7M No change
PHVS Pharvaris NV 3.65% 7,531,252 $132.6M No change
CNTA Centessa Pharmaceuticals Ltd. 3.51% 9,681,818 $127.2M No change
BULL Webull Corp. 2.36% 7,148,051 $85.5M New
EWCZ European Wax Center Inc. Class A 2.03% 13,110,492 $73.8M No change
RPRX Royalty Pharma PLC Class A 1.49% 1,500,000 $54.0M No change
RSKD Riskified Ltd. Class A 0.73% 5,324,998 $26.6M No change
ADAG Adagene Inc.-ADR 0.21% 3,825,952 $7.5M No change
ALMS Alumis Inc. 0.11% 1,297,530 $3.9M New
GROV Grove Collaborative Holdings 0.08% 2,474,859 $2.8M No change

Portfolio Sells Q1 2025 → Q2 2025

ALHC Alignment Healthcare Inc. Reduce -27.9% 16.97% −21.15
IMCR Immunocore Holdings PLC-ADR Sold out 0.00% −1.26
SLRN Acelyrin Inc. Sold out 0.00% −0.22
CONTEXTLOGIC INC - A Sold out 0.00% −0.14
XP XP Inc. Class A Reduce -13.8% 14.20% +0.53

Portfolio Buys Q1 2025 → Q2 2025

CHYM Chime Financial Inc. Class A New 18.26% +18.26
BULL Webull Corp. New 2.36% +2.36
AKRO Akero Therapeutics Inc. Add +9.6% 8.43% +1.32
ALMS Alumis Inc. New 0.11% +0.11

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 12$2.9BLFTO, DLO, CHYM, ALKT, XP
Q1 2026 12$2.1BDLO, CHYM, XP, ALKT, PHVS
Q4 2025 13$2.9BDLO, CHYM, XP, ALKT, ALHC
Q3 2025 16$3.3BDLO, XP, ALHC, CHYM, ALKT
Q2 2025 15$3.6BDLO, CHYM, ALHC, XP, AKRO
Q1 2025 15$3.0BALHC, DLO, XP, ALKT, AKRO
Q4 2024 16$2.8BDLO, ALHC, ALKT, XP, CNTA
Q3 2024 18$3.5BALHC, XP, DLO, SQSP, ALKT
Q2 2024 19$3.2BXP, DLO, ALKT, ALHC, SQSP
Q1 2024 22$4.3BDLO, XP, ALKT, HRT, SQSP